Position in CDXS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$708,251
+$244,295 QoQ
Shares Held
313,386
+10.1% QoQ
Ownership
0.286%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 148 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 18%
None 22%
Common Shares in CDXS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,163,799,259 across 230 Biotechnology names. CDXS ranks #168 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in CDXS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $708,251 | 313,386 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $463,956 | 284,636 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $661,785 | 406,004 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,472,830 | 603,620 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,396,017 | 572,139 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,233,675 | 458,616 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,936,498 | 405,975 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,259,539 | 408,942 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,056,361 | 340,762 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $884,032 | 253,305 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $642,991 | 210,817 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $292,920 | 154,985 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $774,431 | 276,583 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $823,629 | 198,945 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $867,306 | 186,118 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,389,264 | 229,252 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,452,635 | 616,887 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $19,237,532 | 932,955 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $28,928,658 | 925,125 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $19,579,593 | 841,771 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $16,427,185 | 724,942 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $10,507,814 | 459,057 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,702,257 | 261,212 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $2,377,737 | 202,533 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,054,473 | 180,217 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,711,966 | 153,402 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||